Shabbir obtained his PhD degree from Calcutta University, India in collaboration with University of Texas Health Science Center at Tyler, Texas. His thesis focused on understanding the cellular and molecular mechanisms of tissue factor (TF) decryption/activation. Shabbir joined the Schulman lab to further his understanding of TF-mediated thrombosis in various pathological conditions such as sepsis and COVID-19 using primary cell cultures, murine models and clinical samples. Outside the lab, Shabbir likes to spend time with his family and friends. Last but not the least, Shabbir is a rusty but passionate cricketer.

Marisa obtained her PhD in Biomedical Sciences from Oakland University in Michigan. She joined Dr. Sol Schulman’s lab under the support of the T-32 training program. Marisa’s research focus is on understanding the regulation of tissue factor by utilizing mouse models, cell lines, and human samples and how those factors contribute to thrombosis and hemostasis.

Keiichi obtained his PhD from Kyushu University in Japan in biochemistry. He has been working on two projects: 1) the genes which might be involved in tissue factor turnover and stability, and 2) analysis of virus-induced coagulopathy and therapeutic application of novel drugs to treat coagulopathy of sepsis, using in vivo and in vitro systems. Previously he worked on the role of cd39/ENTPDase1 in metabolic disease such as atherosclerosis, diabetes and inflammation at BIDMC.

Shihui received his Ph.D. in Molecular Biology from Salzburg University and initially joined the Flaumenhaft lab as a postdoctoral research fellow with a CSC Scholarship. Currently, he is applying cell and molecular biology techniques to evaluate the molecular mechanisms of protein disulfide isomerase underlying thrombus formation. Additionally, Shihui has had successful collaborations with physician-scientists and research experts on both inter-and intra-organizational teams. He has also expanded his role as a meeting organizer for the Division, a mentor for the young partners, and a reviewer for scientific journals in the field.

3 Blackfan Circle, Room 924
Boston, MA 02115
jludingt@bidmc.harvard.edu

Jacob received his MD, PhD from Tufts University School of Medicine where he studied molecular mechanisms underlying host-pathogen interactions and their role in disease. His interest in hematology led to him joining the Schulman lab to investigate viral processes contributing to COVID-19-associated coagulopathy and perturbations in exosome biogenesis and release.  

Zach graduated from Thomas Jefferson University with his MD and PhD in cell biology and regenerative medicine. He is currently a resident in internal medicine at BIDMC. His research in the Schulman lab is focused on using high-throughput approaches to identify FDA-approved compounds that have off-target effects on tissue factor activity.

Dr. Sharma’s research focuses on the molecular and cellular mechanisms of thrombosis and inflammation, with particular interests in innate immune responses to Vascular injury and Sepsis.  His work also uses Organ-on-Chip platforms to model human organ function to study vascular–immune interactions and drug discovery.

Beyond science, he is actively involved in sports leadership, managing professional Cricket operations across the Northeast region of the United States. He is passionate about mentoring, science communication, and fostering interdisciplinary collaboration between research and sports communities.

Karen is originally from Belgium where she received her Master’s degrees in Biomedical Sciences and Molecular Biotechnology from Ghent University and her PhD in Biochemistry & Biotechnology from the Catholic University of Leuven. Her research has been focused on understanding processes involved in hemostasis and thrombosis and using that knowledge to guide the development of novel therapeutics. She previously worked on conducting translation research to evaluate how endothelial therapies can reduce uncontrolled blood clotting in the setting of infectious disease. ​

Awards:

2015 – Young Investigator Award – International Society on Thrombosis and Haemostasis
2016 to Present – NIH T32 Training Grant
2016 – Translational Research Training in Hematology (TRTH) – Joint EHA and ASH award
2016 – Abstract Achievement Award – American Society of Hematology (ASH)
2017 – Young Investigator Award – International Society on Thrombosis and Haemostasis

Maneli was a postdoctoral research fellow who joined the Flaumenhaft lab in 2018, to study the critical role of the endothelial Angiopoietin-Tie2 pathway in thrombosis. She grew up in Tehran then moved to Boston, after completing her medical school and working as a physician for a couple of years. Outside of the lab, Maneli is a nature and art enthusiast, enjoys spending time with family and friends, along with traveling.

Awards:

2016 to 2018 – International Post Doctoral Fellowship – Swedish Research Council

Natasha grew up in India and received her medical training from prestigious Lady Hardinge Medical College, New Delhi. After completion of her medical training, she worked as physician in India for couple of years and later moved to the United States. She worked on tissue factor under mentorship of Dr. Sol Schulman. Natasha is also an experienced hiker and has hiked many major peaks in New England.

Christian received his Bachelor of Science at Bethany College in West Virginia.  Afterwards he received his Master’s degree at the Indiana University of Pennsylvania and his PhD in Biomedical Sciences from the University of Toledo.  His research interests have been focused on the cellular and molecular basis of peptide and protein secretion.  He conducted research in this lab to demonstrate the movement of distinct populations of alpha-granules in platelets.  Additionally, a portion of his research was focused on endothelial responses to various small molecules.

Justine was a research fellow who joined the Bendapudi Lab under T-32 training program to define and characterize the underlying genetic mechanism of purpura fulminans. She received her M.D. at Boston University School of Medicine and completed her internal medicine residency at Boston Medical Center. Her research aims to advance the understanding and management of hematologic disorders applying genetic sequencing and basic molecular research. Outside of the lab she enjoys spending time with family and friends, eating anything made from carbohydrates and cheese, reading, and traveling.

Noppacharn is originally from Bangkok, Thailand. He received Doctor of Medicine and certified Board of Hematology from Chulalongkorn University. He is a faculty member at Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University. He received a two-year scholarship from Anandamahidol Foundation between 2016-2018 to study in advanced basic science research. His research was focused on thalassemia and hemoglobinopathies as well as hemostasis and thrombosis. His research in this lab were focused on mechanisms of protein disulfide isomerase in regulation of platelet functions and hemostasis and thrombosis models in mice with hemostatic defects.

Awards:

2017 – Abstract Achievement Award – American Society of Hematology (ASH)